Summary of Significant Accounting Policies (Details) - Schedule of Revenue - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Summary of Significant Accounting Policies (Details) - Schedule of Revenue [Line Items]
Total revenues	$ 145	$ 511
Epigenetic biomarker services [Member]
Summary of Significant Accounting Policies (Details) - Schedule of Revenue [Line Items]
Total revenues	99	400
Epigenetic biomarker royalties [Member]
Summary of Significant Accounting Policies (Details) - Schedule of Revenue [Line Items]
Total revenues	27	83
Life insurance commissions [Member]
Summary of Significant Accounting Policies (Details) - Schedule of Revenue [Line Items]
Total revenues	$ 19	$ 28